Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 1,584 shares at $18.94 ($30K) on 2025-01-22, disclosed to the SEC on 2025-01-23.
Seasonal sale ($30k) by CHIEF COMMERCIAL OFFICER — this insider has traded TVTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |